1. Catalogs
  2. Alcon
  3. MODEL SN60WF
video corpo

MODEL SN60WF

MODEL SN60WF
1 / 15 PagesView full catalog

MODEL SN60WF

Product catalog summary
Product Overview
The AcrySof® IQ UV and blue light filtering acrylic foldable single-piece posterior chamber intraocular lens (IOL) by Alcon Laboratories is designed for visual correction of aphakia in adults post-cataract surgery. It features a blue light filtering chromophore that mimics the human crystalline lens, significantly reducing blue light transmittance.
Specifications
The lens is made from a high refractive index soft acrylic material, allowing it to be folded for insertion and then unfold to a full-size lens body post-implantation. It has a biconvex optic with supporting haptics and is designed to reduce spherical aberration.
Mode of Action
The lens is positioned in the posterior chamber, replacing the natural lens to function as a refractive medium, intended to reduce spherical aberration compared to standard spherical optics.
Indications and Contraindications
Indicated for visual correction of aphakia in adults post-cataract surgery, it is not suitable for patients with conditions like choroidal hemorrhage, severe eye disease, or glaucoma.
Warnings and Precautions
Potential complications include corneal damage, retinal detachment, and glaucoma. The safety in patients with preexisting ocular conditions has not been substantiated. Regular postoperative monitoring is advised.
Directions for Use
Ensure sterility before implantation, handle by the haptic portion only, and rinse with sterile intraocular irrigating solution. Use appropriate surgical techniques and instrumentation.
Patient Registration and Reporting
Patients must be registered with Alcon Laboratories post-implantation for long-term follow-up. Adverse events should be reported to Alcon.
Clinical Studies
Two clinical studies demonstrated the safety and effectiveness of the AcrySof® lenses, comparing models with and without blue light filtering.
Introduction
The document presents a clinical study comparing the AcrySof® Natural Single-Piece Lens Model SB30AL with a traditional spherical control lens, focusing on visual correction of aphakia and other clinical outcomes.
Patient Population
The study involved a predominantly Caucasian population with a mean age of approximately 72 years, with 70.6% female and 29.4% male for the SB30AL lens group.
Visual Acuity
Results showed no statistically significant difference between the SB30AL and the control lens (SA30AL) in both best-case and overall patient populations.
Adverse Events
The cumulative and persistent adverse events were similar between the SB30AL and SA30AL lenses, with common events including macular edema and lens dislocation.
Color Perception
Testing indicated that the proprietary chromophore in the SB30AL lens did not negatively affect color vision.
Nd:YAG Rates
The incidence of Nd:YAG posterior capsulotomy was low and comparable between the SB30AL and SA30AL lenses.
AcrySof® IQ Lens Study
The AcrySof® IQ lens demonstrated statistically significant improvements in ocular spherical aberrations and contrast sensitivity compared to the control lens, with enhanced performance in simulated night driving conditions.
Conclusion
The AcrySof® Natural Single-Piece Lens Model SB30AL and the AcrySof® IQ lens provide effective visual correction with comparable safety profiles to traditional lenses, with the AcrySof® IQ lens offering additional benefits in contrast sensitivity and functional vision.
Specifications and Procedures
The document discusses the AcrySof® IQ Intraocular Lens (IOL) and its performance in night driving simulations, highlighting improved sight distances under various conditions.
Product Supply and Handling
Lenses are supplied dry and sterilized with ethylene oxide, to be opened under aseptic conditions. Expired lenses should be returned to Alcon Laboratories.
Returned Goods Policy
In the U.S., returned lenses are accepted only for exchange, not credit. Returns require a Returned Goods Number from Alcon’s Customer Service.
References
The document cites studies and articles related to ocular media transmission and complications of intraocular lenses.
Symbols Used on Labeling
Provides a list of symbols used in labeling, such as IOL for Intraocular Lens, PC for Posterior Chamber, and UV for Ultraviolet.
Manufacturer Information
Alcon Laboratories, Inc. is the manufacturer, with contact details provided for both the U.S. and UK offices.
See more

Catalog excerpts

MODEL SN60WF-1

PRODUCT INFORMATION Alcon Laboratories, Inc. R

 Open the catalog to page 1
MODEL SN60WF-2

PRODUCT INFORMATION Alcon Laboratories, Inc. CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician. Model Characteristics Chart Model Optic Type Haptic Angle Anterior Asymmetric Biconvex DESCRIPTION The AcrySof® IQ UV and blue light filtering acrylic foldable single-piece posterior chamber intraocular lens (IOL) is an optical implant for the replacement of the human crystalline lens in the visual correction of aphakia in adult patients following cataract surgery. The AcrySof® IQ lens with Alcon’s proprietary blue light filtering chromophore filters light in...

 Open the catalog to page 2
MODEL SN60WF-3

Figure 2 Spectral Transmittance Curves crystalline lens NOTES: • The cutoff wavelength and the spectral transmittance curves presented here represent the range of transmittance values of IOLs made from acrylate/methacrylate copolymer with bonded UV-absorber and Alcon’s proprietary blue light filtering chromophore. • Measurements were by direct transmittance using a 6mm aperture and a disc of thickness equivalent to the optic center. • Human lens data is from Boettner and Wolter (1962). Table 1 Transmittance Comparison for 20.0 D IOLs, % Model Transmittance Reduction with SN60WF (% of SA60AT)...

 Open the catalog to page 3
MODEL SN60WF-4

MODE OF ACTION The AcrySof® IQ posterior chamber intraocular lens is intended to be positioned in the posterior chamber of the eye, replacing the natural crystalline lens. This position allows the lens to function as a refractive medium in the correction of aphakia. The aspheric biconvex optic reduces spherical aberration as compared to a standard spherical optic in an average eye. The effectiveness of this lens in reducing the incidence of retinal disorders has not been established. INDICATIONS The AcrySof® IQ posterior chamber intraocular lens is indicated for the replacement of the human lens...

 Open the catalog to page 4
MODEL SN60WF-5

Postoperative distension of the capsular bag with variable amounts of anterior chamber shallowing and induced myopia have been associated with capsulorhexis techniques and implantation of PMMA, silicone and acrylic posterior chamber lenses (Holtz, 1992). 10. Caution should be used prior to lens encapsulation to avoid lens decentrations or dislocations. Some clinical cases suggest encapsulation occurs within four weeks. 11. The clinical study of the AcrySof® Natural Single-Piece Lens (referenced in Tables 2 through 5) was conducted with the lens intended for implantation in the capsular bag only....

 Open the catalog to page 5
MODEL SN60WF-6

CALCULATION OF LENS POWER Preoperative calculation of required lens power for these posterior chamber intraocular lenses should be determined by the surgeon’s experience, preference, and intended lens placement. Lens power calculation methods are described in the following references: Hoffer, K.J. The Hoffer Q formula: A comparison of theoretic and regression formulas. J. Cataract Refract. Surg. 19:700-712, 1993. Holladay, J.T., et al. A three-part system for refining intraocular lens power calculations. J. Cataract Refract. Surg. 14:17-24, 1988. Holladay, J.T., et al. Standardizing constants...

 Open the catalog to page 6
MODEL SN60WF-7

Table 2b Best Corrected Visual Acuity in the Best Case Patient Population at a Minimum of One Year Postoperatively, AcrySof® Lens SA30AL control Acuity 20/20 or Better N % Table 3a Best Corrected Visual Acuity in the Overall Patient Population at a Minimum of One Year Postoperatively, AcrySof® Lens Natural SB30AL Acuity 20/20 or Better Table 3b Best Corrected Visual Acuity in the Overall Patient Population at a Minimum of One Year Postoperatively, AcrySof® Lens SA30AL control Acuity #Per N

 Open the catalog to page 7
MODEL SN60WF-8

AcrySof® Natural SINGLE-PIECE LENS Model SB30AL CUMULATIVE ADVERSE EVENTS The cumulative rates of these adverse events up to and including a minimum of a one year postoperative period for the AcrySof® Natural Single-Piece Lens Model SB30AL and the Model SA30AL patients are shown in Table 4. There were no statistically significant differences between the Model SB30AL and the Model SA30AL for the proportion of subjects experiencing any of the cumulative adverse events. Table 4 Cumulative Adverse Events at a Minimum of One Year Postoperatively AcrySof® Natural Lens SB30AL and SA30AL control SB30AL...

 Open the catalog to page 8
MODEL SN60WF-9

AcrySof® Natural SINGLE-PIECE LENS Model SB30AL Nd:YAG RATES With a mean follow-up of 21.6 months, three (3) of the 135 subjects (2.2%) implanted with SB30AL experienced a Nd:YAG posterior capsulotomy. With a mean follow-up of 21.9 months, two (2) of the 127 subjects (1.6%) implanted with SA30AL experienced a Nd: YAG posterior capsulotomy. AcrySof® IQ LENS CLINICAL STUDY Consistent with the design of similar previously conducted IOL studies, adult subjects in good general ocular health (e.g. no prior ocular surgery, degenerative visual disorder which would significantly impact visual acuity,...

 Open the catalog to page 9
MODEL SN60WF-10

Figure 5 Mean Spherical Aberration Overall and by Age Group 90-120 Days after 2nd Eye Implant Control Mean Spherical Aberration (micrometers) * AcrySof® IQ LENS – DISTANCE VISUAL ACUITY The AcrySof® IQ lens and the control lens provided clinically similar postoperative visual acuity. Monocular visual acuity results are presented in Figures 6 and 7. Figure 6 LogMAR BCVA Days Postoperative * Quantitative Lens Model Main Effect (p=0.0214)

 Open the catalog to page 10
MODEL SN60WF-11

LogMAR UCVA ■ AcrySof® IQIOL (N=77) □ Control (N=75) 1-2 Days 7-14 Days 30-60 Days Days Postoperative Differences are not statistically significant AcrySof® IQ LENS -CONTRAST SENSITIVITY The primary objective of the clinical investigation was to demonstrate superiority of the AcrySof® IQ lens over the control lens via mean contrast sensitivity measured postoperatively under mesopic conditions with or without glare at either of two spatial frequencies (3 or 6 cycles per degree) using the Vector Vision CSV-1000 (with chart luminance of 3 cd/ m2). In a subset of patients, the Functional Acuity Contrast...

 Open the catalog to page 11
MODEL SN60WF-12

Figure 9 Mesopic Contrast Sensitivity (FACT) Substudy Minimum of 90 days after 2nd Eye Implant Contrast Sensitivity (Log Units) Contrast Level/Condition * Hommel’s adj p-value AcrySof® IQ LENS – NIGHT DRIVING SIMULATION A subset of patients underwent testing in a validated night driving simulator. Patients were tested monocularly under conditions which simulate city and rural settings under normal, glare and fog conditions. The nighttime city driving scene employs a variety of street lights, car lights, store lights and signs to recreate the high level of ambient lighting typical under these...

 Open the catalog to page 12
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.